| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |